The N4 research group are starting up several new clinical trials in the autumn and winter of 2022. We plan to provide a brief introduction to each project over the coming months, and will start with ‘Growth, ALlergy and NeuroDevelopment in Infants On hydrolySed formulA’, or GRANDIOSA. GRANDIOSA is a blinded, placebo-controlled, randomized clinical trial […]
Read More![](https://usercontent.one/wp/www.n4researchgroup.se/wp-content/uploads/2022/09/MainLogo_WebPreview_Grandiosa-scaled.jpg)